Christopher Seaton, MD
Anesthesiology · West Hollywood, CANPI 1124518592
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.6%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 45.2% of the total. Reporting peaked in 2023 at $6,389 and has fallen 54.2% since, to $2,929 in 2025. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 367 payments — averaging $54.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Abbott$4K
- Biotronik NRO, Inc.$2K
- Boston Scientific$2K
- Nevro Corp.$468
- Relievant Medsystems, Inc.$410
- plus $2K from 18 others
What the payments were for
- Grants$3,75019%
- Travel & lodging$4,76124%
- Food & beverage$11,55558%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 128 | $9,079 |
| Abbott | 40 | $4,345 |
| Biotronik NRO, Inc. | 107 | $2,088 |
| Boston Scientific | 29 | $1,590 |
| Nevro Corp. | 10 | $468 |
| Relievant Medsystems, Inc. | 2 | $410 |
| Saluda Medical Americas, Inc. | 5 | $410 |
| Avanos Medical | 3 | $302 |
| SPR Therapeutics, Inc | 3 | $247 |
| Stratus Medical, LLC | 1 | $165 |
| IBSA Pharma Inc. | 7 | $155 |
| Vertex | 4 | $147 |
| Si-bone, Inc. | 5 | $142 |
| Virtus Pharmaceuticals LLC | 4 | $97 |
| Nalu Medical, Inc. | 4 | $93 |
| Globus Medical | 3 | $86 |
| Valinor Pharma, LLC | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 3 | $43 |
| Merz Pharmaceuticals, LLC | 1 | $31 |
| Bioventus LLC | 1 | $27 |
| DJO, LLC | 1 | $23 |
| Curonix LLC | 1 | $19 |
| Spinal Simplicity, LLC | 1 | $19 |
| Hydrocision, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$3,750
- PROCLAIM$3,381
- INTELLIS ADAPTIVESTIM$1,650
- Intracept$1,500
- VANTA ADAPTIVESTIM$1,437
- Prospera$384
- WaveWriter Alpha Prime 16$310
- Omnia$275
- Evoke$269
- Superion Indirect Decompression System$250
- Nimbus$165
- GENERAL - THERAPIES$163
- GENERATOR$150
- GENERAL PAIN MANAGEMENT$145
- COOLIEF* COOLED RADIOFREQUENCY$134
- KYPHON EXPRESS II KYPHOPAK TRAY$125
- SPRINT PNS System$118
How this compares
$20,065 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LicartDiclofenac Epolamine | 11 | $8,641 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $744 |
| Pregabalin | 19 | $561 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $323 |
| Oxycodone Hcl | 16 | $240 |
| Gabapentin | 40 | $221 |
| Meloxicam | 44 | $151 |
| Tramadol Hcl | 19 | $81 |
| Methocarbamol | 15 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| IBSA Pharma Inc.Licart | $155 | $8,64111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,717 anesthesiology providers in California.
Other anesthesiology in West Hollywood
- Jack JengSouth San Francisco$1.3M
- Roger PhillipsChico$434K
- David DeyhimyLaguna Hills$344K
- Maxime CannessonLos Angeles$336K
- Alexander RoherSan Diego$282K
- Moody MakarLos Angeles$252K
- Jonathan JahrLos Angeles$223K
- Amir ShbeebLong Beach$216K
- Lawrence ChuStanford$205K
- Hendrikus LemmensStanford$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.